{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:47:44Z","timestamp":1792468064046,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.actbio.2026.06.031","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:51:04Z","timestamp":1781592664000},"page":"590-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Endocytosis-dependent and spleen-selective mRNA expression enabled by ionizable lipidoid linkers enhances therapeutic mRNA vaccination"],"prefix":"10.1016","volume":"219","author":[{"given":"Lin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-094X","authenticated-orcid":false,"given":"Guanjun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.actbio.2026.06.031_bib0001","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41571-024-00867-1","article-title":"Personalized neoantigen mRNA vaccine mitigates melanoma recurrence","volume":"21","author":"Killock","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2026.06.031_bib0002","article-title":"Polyplex designs for improving the stability and safety of RNA therapeutics","volume":"199","author":"Satoshi","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.031_bib0003","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Eduarde","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.actbio.2026.06.031_bib0004","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"J","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.031_bib0005","article-title":"Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques","volume":"3","author":"Huang","year":"2024","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.031_bib0006","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s41467-024-47460-9","article-title":"Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria","volume":"15","author":"Baek","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.actbio.2026.06.031_bib0007","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s43018-024-00850-w","article-title":"Personalized neoantigen therapy for melanoma immunotherapy","volume":"5","author":"Danelli","year":"2024","journal-title":"Nat. Cancer"},{"issue":"51","key":"10.1016\/j.actbio.2026.06.031_bib0008","article-title":"LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Yan","year":"2023","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.actbio.2026.06.031_bib0009","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"P","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"46","key":"10.1016\/j.actbio.2026.06.031_bib0010","article-title":"Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection","volume":"35","author":"Runnan","year":"2023","journal-title":"Adv. Mater."},{"issue":"8045","key":"10.1016\/j.actbio.2026.06.031_bib0011","first-page":"1","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2024","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.actbio.2026.06.031_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning lipid nanoparticles for RNA delivery to extrahepatic organs","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.actbio.2026.06.031_bib0013","first-page":"428","article-title":"Strategies for non-viral vectors targeting organs beyond the liver","volume":"19","author":"Jeonghwan","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2026.06.031_bib0014","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Wayne","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.actbio.2026.06.031_bib0015","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Yeji","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"67","key":"10.1016\/j.actbio.2026.06.031_bib0016","doi-asserted-by":"crossref","first-page":"eabj0641","DOI":"10.1126\/sciimmunol.abj0641","article-title":"A diverse fibroblastic stromal cell landscape in the spleen directs tissue homeostasis and immunity","volume":"7","author":"O","year":"2022","journal-title":"Sci. Immunol."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.031_bib0017","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41577-023-00857-x","article-title":"Splenic stromal niches in homeostasis and immunity","volume":"23","author":"O","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"33","key":"10.1016\/j.actbio.2026.06.031_bib0018","doi-asserted-by":"crossref","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.actbio.2026.06.031_bib0019","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Camilla","year":"2022","journal-title":"Adv. Drug Deliv. Rev"},{"issue":"15","key":"10.1016\/j.actbio.2026.06.031_bib0020","article-title":"Unsaturated, trialkyl ionizable lipids are versatile LNP components for therapeutic and vaccine applications","volume":"35","author":"Kieu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2026.06.031_bib0021","doi-asserted-by":"crossref","first-page":"26934","DOI":"10.1021\/jacs.5c09030","article-title":"Combinatorial synthesis and evaluation of trialkyl galloyl amidoamine ionizable lipids for mRNA formulation","volume":"147","author":"Golba","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2026.06.031_bib0022","first-page":"1","article-title":"Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity","author":"Gong","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.actbio.2026.06.031_bib0023","doi-asserted-by":"crossref","first-page":"28665","DOI":"10.1021\/jacs.5c01389","article-title":"Carbonate-bearing ionizable lipids for mRNA delivery to splenic NK cells","volume":"147","author":"Wu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2026.06.031_bib0024","first-page":"1","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.031_bib0025","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41551-024-01267-7","article-title":"Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution","volume":"8","author":"Han","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.actbio.2026.06.031_bib0026","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/jacs.4c00451","article-title":"Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2026.06.031_bib0027","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein\u2013Barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.actbio.2026.06.031_bib0028","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein\u2013Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"20","key":"10.1016\/j.actbio.2026.06.031_bib0029","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Blossom","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2026.06.031_bib0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990\u20132010","volume":"9","author":"Gulfaraz","year":"2014","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.actbio.2026.06.031_bib0031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41698-017-0018-x","article-title":"EBV based cancer prevention and therapy in nasopharyngeal carcinoma","volume":"1","author":"Cao","year":"2017","journal-title":"Npj Precis. Oncol."},{"issue":"5","key":"10.1016\/j.actbio.2026.06.031_bib0032","doi-asserted-by":"crossref","first-page":"565","DOI":"10.7150\/ijbs.24562","article-title":"Epstein-Barr virus-encoded microRNAs as regulators in host immune responses","volume":"14","author":"Man","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"107","key":"10.1016\/j.actbio.2026.06.031_bib0033","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr Virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2026.06.031_bib0034","doi-asserted-by":"crossref","first-page":"0370","DOI":"10.34133\/research.0370","article-title":"Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies","volume":"7","author":"Huang","year":"2024","journal-title":"Research"},{"issue":"5","key":"10.1016\/j.actbio.2026.06.031_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Kalina","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.actbio.2026.06.031_bib0036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Jeonghwan","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.actbio.2026.06.031_bib0037","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jacs.2c10670","article-title":"Iterative design of ionizable lipids for intramuscular mRNA delivery","volume":"145","author":"Grayson","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.031_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.110849","article-title":"Nucleic acid delivery by lipid nanoparticles for organ targeting","volume":"36","author":"Guo","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"4","key":"10.1016\/j.actbio.2026.06.031_bib0039","article-title":"Lipid nanoparticles optimized for targeting and release of nucleic acid","volume":"36","author":"Yaru","year":"2023","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.031_bib0040","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","article-title":"Acid-degradable lipid nanoparticles enhance the delivery of mRNA","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"41","key":"10.1016\/j.actbio.2026.06.031_bib0041","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady6460","article-title":"Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.031_bib0042","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein\u2013Barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"02","key":"10.1016\/j.actbio.2026.06.031_bib0043","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11427-024-2766-0","article-title":"Research landmarks on the 60th anniversary of Epstein-Barr virus","volume":"68","author":"Zhong","year":"2025","journal-title":"Sci. China"},{"issue":"1","key":"10.1016\/j.actbio.2026.06.031_bib0044","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10330-016-0187-7","article-title":"Advantages and limitations in the establishment and utilization of patient-derived xenografts in gastric cancer","volume":"3","author":"Chen","year":"2017","journal-title":"Oncol. Transl. Med."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.031_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/ot9.0000000000000071","article-title":"Advances in basic and translational research into nasopharyngeal carcinoma","volume":"11","author":"Li","year":"2025","journal-title":"Oncol. Transl. Med."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126003910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126003910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:32:42Z","timestamp":1785702762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126003910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S1742706126003910"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.031","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocytosis-dependent and spleen-selective mRNA expression enabled by ionizable lipidoid linkers enhances therapeutic mRNA vaccination","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}